The pharmaceutical giant raised its full-year guidance after third-quarter revenue and core earnings per share topped ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

AstraZeneca's price plunge following a fraud investigation in China could be just the time to buy AZN stock as big picture ...

AstraZeneca (GB:AZN) has released an update. Michel Demaré, the Non-Executive Chair of AstraZeneca, recently purchased 2,000 ordinary shares of ...

AstraZeneca's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected ...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good ...

Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...

The OBR (Office for Budget Responsibility) anticipates economic output in Britain to expand by 1.8% in 2026 and by 1.5% in ...

AstraZeneca (GB:AZN) has released an update. AstraZeneca’s CEO, Pascal Soriot, has made a substantial investment in the company by ...

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...

AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former ...